Markets
Tuesday, 7/21, 07:16 AM
Novartis sales edge up 1%, and it holds a guidance that still sees income falling
- Novartis reported second-quarter net sales of $14.408 billion, up 3% in dollars but only 1% in constant currencies, with core operating income flat.
- It reaffirmed full-year guidance that expects sales to grow at a low single-digit rate while core operating income declines at a low single-digit rate.













